Absci (ABSI) Enterprise Value (2020 - 2026)
Absci (ABSI) posted Enterprise Value of -$125.7 million for Q1 2026, up 12.88% sequentially from -$144.3 million in Q4 2025, and up 6.18% YoY from -$118.4 million in Q1 2025.
Absci (ABSI) Enterprise Value (2020 - 2026) Analysis & Trends
Absci has reported Enterprise Value for 7 years, with the latest figure at -$125.7 million in Q1 2026.
- Quarterly Enterprise Value rose 6.18% year-over-year to -$125.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$125.7 million (up 6.18% YoY) and the FY2025 annual result came in at -$144.3 million, down 28.35% from the prior year.
- Enterprise Value grew to -$125.7 million in Q1 2026 per ABSI's latest filing, from -$144.3 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$50.0 million in Q2 2022 and troughed at -$226.0 million in Q1 2022.
- A 5-year average of -$136.6 million and a median of -$134.0 million in 2025 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2023: Enterprise Value slumped 180.74% in 2022, then jumped 40.61% in 2023.
- Over 5 years, Enterprise Value stood at -$164.4 million in 2022, then surged by 40.61% to -$97.7 million in 2023, then decreased by 15.12% to -$112.4 million in 2024, then declined by 28.35% to -$144.3 million in 2025, then rose by 12.88% to -$125.7 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$125.7 million, -$144.3 million, and -$152.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Absci | 1.58 Bn | 1.37 Bn | - | -201.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -201.14 Mn |
| Mar 31, 2026 | -125.71 Mn |
| Dec 31, 2025 | -144.29 Mn |
| Sep 30, 2025 | -152.48 Mn |
| Jun 30, 2025 | -117.46 Mn |
| Mar 31, 2025 | -133.98 Mn |
| Dec 31, 2024 | -112.43 Mn |
| Sep 30, 2024 | -127.07 Mn |
| Jun 30, 2024 | -145.25 Mn |
| Mar 31, 2024 | -161.54 Mn |
| Dec 31, 2023 | -97.66 Mn |
| Sep 30, 2023 | -113.48 Mn |
| Jun 30, 2023 | -124.59 Mn |
| Mar 31, 2023 | -144.26 Mn |
| Dec 31, 2022 | -164.43 Mn |
| Sep 30, 2022 | -181.31 Mn |
| Jun 30, 2022 | -50.00 Mn |
| Mar 31, 2022 | -226.00 Mn |
| Dec 31, 2021 | -252.57 Mn |
| Sep 30, 2021 | -279.26 Mn |